The exit comes as Trenkle accepts his new position at Novo Ventures, the venture capital arm of Novo Holdings.
Jim Trenkle announced his departure from the French corporate venture firm Sanofi Ventures, the corporate arm of pharmaceutical conglomerate Sanofi.
Trenkle will work as a partner for Denmark-based venture capital firm Novo Ventures, a subsidiary of Novo Holdings, which is part of global medical treatment foundation Novo Nordisk Foundation.
“After a wonderful couple years in Boston, I’m delighted to be back in the Bay Area…
